Dolby Laboratories, Inc. [NYSE:DLB]: Analyst Rating and Earnings

Equities traders oftentimes stay updated on what leading stock market analysts say about a potential stock purchase. When it comes to Dolby Laboratories, Inc. [DLB], the most recently available average analyst rating is from the quarter that ends in September. On average, stock market experts give DLB an Outperform rating. Its stock price has been found in the range of 1.85 to 4.05. This is compared to its latest closing price of $62.83.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Dolby Laboratories, Inc. [DLB] is sitting at 2.14. This is compared to 1 month ago, when its average rating was 2.14.

For the quarter ending in Dec-18 Dolby Laboratories, Inc. [DLB] generated $0.3 billion in sales. That’s 2.49% higher than the average estimate of $0.3 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.

Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Tue 23 Apr (In 69 Days).

Fundamental Analysis of Dolby Laboratories, Inc. [DLB]

Now let’s turn to look at profitability: with a current Operating Margin for Dolby Laboratories, Inc. [DLB] sitting at +25.56 and its Gross Margin at +89.06, this company’s Net Margin is now 25.50%. These measurements indicate that Dolby Laboratories, Inc. [DLB] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is 13.80, and its Return on Invested Capital has reached 6.70%. Its Return on Equity is 5.65, and its Return on Assets is 4.70. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates DLB financial performance.

What about valuation? This company’s Enterprise Value to EBITDA is 14.19. The Enterprise Value to Sales for this firm is now 4.55. Dolby Laboratories, Inc. [DLB] has a Price to Book Ratio of 3.30, a Price to Cash Flow Ratio of 21.25 and P/E Ratio of 22.59. These metrics suggest that this publicly-traded organization will not likely result in investment gains.

Shifting the focus to workforce efficiency, Dolby Laboratories, Inc. [DLB] earns $544,828 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 10.86 and its Total Asset Turnover is 0.45. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.69 and its Current Ratio is 4.78. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Performance Indicators

Let’s now turn our attention to trading performance: Dolby Laboratories, Inc. [DLB] has 103.88M shares outstanding, amounting to a total market cap of $6.65B. Its stock price has been found in the range of 58.17 to 72.04. At its current price, it has moved by -11.12% from its 52-week high, and it has moved 10.07% from its 52-week low.

This stock’s Beta value is currently 0.88, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 48.86. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Dolby Laboratories, Inc. [DLB] a Reliable Buy?

Shares of Dolby Laboratories, Inc. [DLB], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.